Putting spam back in the can wont be all that easy ( te laws against spam should clean up yo...)

Putting spam back in the can wont be all that easy

te laws against spam should clean up your e-mail inbox, right?

Not necessarily. The enactment of the federal CAN-SPAM Act in January provided the basis for the lawsuits filed last week, but experts say the law passed by Congress may legitimize some spam as it seeks to ban other unsolicited messages. CAN-SPAM (Controlling the Assault of Non-Solicited Pornography and Marketing Act of 2003) ......

Full article >>>

Source:wistechnology.com By Tom Still 03/17/04

Page: 1 2
Related biology technology :

1. Fact and friction: Putting election-year stem cell claims under the microscope

Post Your Comments:

(Date:11/6/2009)..., SAN MATEO, Calif., Nov. 6 /PRNewswire-FirstCal... Completed transfer of Qutenza(TM) E.U. Marketing ...e significant progress in commercial readiness act...les; Senior Director, Marketing; and Director, Com...to board as director and Audit Committee chairman ...

(Date:11/6/2009)..., CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncol...tics" or the "Company") today announced updated re...N(R) in patients with sarcomas metastatic to the l...nnective Tissue Oncology Society Meeting held in M... poster presentation, entitled "A Phase II Study o...

(Date:11/6/2009)... The agenda for Arrowhead&r...ference, which is set to take place on February 22...this three day conference we will highlight key is...peakers to share their experiences. , ...009 -- The agenda for Arrowhead’s 2010 Pers...

(Date:11/5/2009)..., GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCal...d its financial results for the third quarter ende...f $3.6 million ($0.04 per share) for the three mon...s of $6.8 million ($0.08 per share) in the compara...tember 30, 2009, GenVec,s net loss was $14.1 milli...

[0] NeurogesX Reports Third Quarter 2009 Results [0] Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting [0] Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference [0] GenVec Reports Third Quarter 2009 Financial Results

...he Maryland Stem Cell Research,Commission (Commiss... for,new post-doctoral fellowship grants under RFA...applications from pre-doctoral students and post-,...translational research on,all types of human stem ... fellowships will be funded with each,fellowship b...

...Raptor,Pharmaceuticals Corp. ("Raptor" or the "Com... that its clinical development division, Bennu,Pha...al product candidate,EC Cysteamine. Bennu received... developed by clinical scientists at the Universit... way of its acquisition by,merger of Encode Pharma...

... 17 , - New Deal Provides a Further Opportunity f... Oxford Genome Sciences (UK) Ltd "OGeS" announces...oration with Amgen to discover, develop and,commer...ment of cancer.,This new collaboration will enable...human therapeutic antibodies (mAbs) in cancer base...

Other Biology Technology:Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants 2 Raptor Pharmaceuticals Acquires Orphan Clinical Program 2 Raptor Pharmaceuticals Acquires Orphan Clinical Program 3 Raptor Pharmaceuticals Acquires Orphan Clinical Program 4 Raptor Pharmaceuticals Acquires Orphan Clinical Program 5 Raptor Pharmaceuticals Acquires Orphan Clinical Program 6 Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer 2 Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer 3

Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants Raptor Pharmaceuticals Acquires Orphan Clinical Program Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer

(Date:11/8/2009)...E, Ind. - Researchers at Purdue University have di...e fibers in spinal cord injuries using nano-sphere...ter an accident. , The synthetic "copolymer mice...s in diameter, or roughly 100 times smaller than t...ave been studying how to deliver drugs for cancer ...

(Date:11/6/2009)...stration is now open for the Society of Interventi...logy (IO) Therapies" Webinar, which will provide t...r treatment of liver tumors, kidney tumor ablation...zation of physicians, scientists and allied health...h through pioneering advances in image-guided ther...

(Date:11/6/2009).... 6 Auburn Hills, MI-based Law Enf...nstalling its locker system and patent-pending Bio.... Department of Health and Human Services, Nationa.... The locker system will support the NIH,s entire...ur nation,s medical research agency. The project ...

[1] Findings show nanomedicine promising for treating spinal cord injuries [1] Society of Interventional Radiology hosts oncology therapies Webinar, offers resources [0] National Institutes of Health Secures Armory with Patent-Pending Technology

...which trauma and burn patients are most likely to ...wide range of experimental clinical settings ?an i...outinely used in emergency rooms and intensive car...in the Proceedings of the National Academy of Scie...ng the University of Florida, describe how they we...

...iego (UCSD) have found that Lafora disease, an inh...he age of 30, can be caused by mutations in a gene...aforin. These findings are reported in the current...ciences (PNAS). , Lafora disease is characterized ..., followed by an initial seizure in the second dec...

...cancers from Nigeria, Senegal and North America ha...kely to be diagnosed with a more virulent form of ...searchers from the University of Chicago, working ...geria and the University of North Carolina, found ...ferent pattern of gene expression. Tumors from Afr...

Other Biology News:Doctors closer to using gene analysis to help trauma patients 2 Doctors closer to using gene analysis to help trauma patients 3 UCSD research reveals mechanism involved with type of fatal epilepsy 2 Study reveals dramatic difference between breast cancers in US and Africa 2 Study reveals dramatic difference between breast cancers in US and Africa 3 Study reveals dramatic difference between breast cancers in US and Africa 4

Doctors closer to using gene analysis to help trauma patients UCSD research reveals mechanism involved with type of fatal epilepsy Study reveals dramatic difference between breast cancers in US and Africa

Rabbit Anti-Chicken IgY, IgG F(ab')2 fragment Antibody, Biotin Conjugated from Biomeda Corporation

Anti-Chloride Channel, CLC-2 Polyclonal Antibody, Unconjugated from CHEMICON

... 2, Monoclonal Antibody, Unconjugated Applicati...ICC: Use at an assay dependent dilution. WB: Use a...ion is determined using a whole extract of rat bra... in other applications. Optimal dilutions/concent...

Anti-TWIK-2 (Kcnk6, TOSS) Polyclonal Antibody, Unconjugated from CHEMICON

Biology Products:

Rabbit Anti-Chicken IgY, IgG F(ab')2 fragment Antibody, Biotin Conjugated from Biomeda Corporation Anti-Chloride Channel, CLC-2 Polyclonal Antibody, Unconjugated from CHEMICON Mouse Anti-Cytohesin 2 Monoclonal Antibody, Unconjugated, Clone CYT2-21 from Novus Biologicals Anti-TWIK-2 (Kcnk6, TOSS) Polyclonal Antibody, Unconjugated from CHEMICON

( te laws against spam should clean up yo...)Putting spam back in the can wont be all that easy